Found 0 matching trials
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach PHASE1 The few reports on effects of psychedelic substances on cerebral metabolic ...
Show More Location
Department of Nuclear Medicine, Bern University Hospital
Learn More & Join Trial
CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches NA This is a two-site, open-label, randomized, 5-way cross-over study designed...
Show More Learn More & Join Trial
A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster PHASE1 This is a randomized, double-blinded, placebo-controlled, dose-escalation s...
Show More Location
Multiple Locations
Learn More & Join Trial
Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods NA The purpose of this study is to quantify the amount of diclofenac in rinse ...
Show More Learn More & Join Trial
QSPainRelief-patientCNS : Clinical Biomarkers of Nociception, Sedation and Cognition NA QSPainRelief-patientCNS is a monocentric prospective longitudinal study con...
Show More Location
Cliniques universitaires Saint-Luc
Learn More & Join Trial
Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS. NA The aim of this study is to assess the effect of interval hypoxy-hyperoxic ...
Show More Location
University Clinical Hospital №1 Sechenov University
Learn More & Join Trial
Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants NA A Phase IV, open-label, adaptive, 4-arm, multi-dose, single-centre, explora...
Show More Learn More & Join Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) PHASE2 This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer PHASE2 This phase II trial compares the effect of usual radiation therapy with cis...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection PHASE1 This is a research study to evaluate the safety, tolerability and anti-vira...
Show More Location
Impact Clinical Trials
Learn More & Join Trial